PTGS2 and neoplasm: In addition, the correlation between COX-2 and the EGFR pathway in tumorigenesis has been demonstrated, suggesting that combination therapy with COX-2 and EGFR inhibitors would be more effective in tumor suppression than either agent alone [22, 36].